2019 Oral Dosage Forms Market Overview and Outlook (3rd Edition)

Description

Market dominance and a long history of oral dosage forms make this category of drug product a strong candidate for outsourced manufacturing, including to CMOs in emerging markets. This report provides an overview of the current market dynamics in the oral dose contract manufacturing space as well as an outlook of what our survey respondents—all oral dose outsourcing decision-makers at sponsor organizations—predict the marketplace will look like in 2024. Key statistics include oral dose project volume, percentage outsourced, and the average number of CMOs used to complete the work; an analysis of 17 different oral dosage forms which includes utilization rates, the percentage of marketed oral dose products for each form, the proportion of manufacturing that is outsourced by form, and a breakdown of outsourcing expenditure by form as well as which oral dosage forms will grow in use over the next five years and which may lose market share. Additionally, outsourcers will share insights on what works and what hasn’t worked when partnering with CMOs for oral drug product manufacturing.

Preview cover for 2019 Oral Dosage Forms Market Overview and Outlook 3rd Edition

Drug Developers

  • Learn the benefits and risks of offshoring oral dose manufacturing to emerging market CMOs
  • Improve your understanding of the service provider selection and satisfaction drivers that have contributed to positive sponsor-CMO relationships among peers in the recent past, including verbatim responses on CMO preference
  • Discover which life cycle extension strategies are being considered by peers as well as what peers believe will drive growth in the oral dosage forms market

Contract Manufacturers

  • Know which oral dose technologies and capabilities are increasing in demand among sponsor organizations so that CMOs can prepare for these fluctuations
  • Gain insight into oral dose project volume and outsourcing propensity by company size to develop more targeted business development strategies
  • Understand which CMO attributes influence service provider selection for both simple and complex oral dose drug product manufacturing in order to more effectively market your company’s capabilities and services
  • Market Dynamics
  • Service Provider Perceptions and Selection
  • Trends, Predictions, Preferences
  • Geographic Preferences
  • Study Data

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

Sample Page from Preview-2019 Oral Dosage Forms Market Overview and Outlook (3rd Edition)

Market Dynamics

Primary Section Takeaways
Oral Dosage Outsourcing Penetration
Outsourcing Penetration by Company Size
Outsourcing Penetration by Company Size
Current Oral Dose Project & CMO Volume
Oral Dose Project & CMO Volume in 5 Years
Top Five Oral Dosage Forms
Oral Dosage Forms—Anticipated Areas of Growth

Service Provider Perceptions and Selection

Primary Section Takeaways
Service Provider Selection Attributes—Complex Projects
Service Provider Selection Attributes—Simple Projects
Reasons for Service Provider Preference
Service Provider Satisfaction Drivers
Reasons Service Providers Lose Bids
Number of Preferred Providers
Trends, Predictions, and Preferences
Primary Section Takeaways
Oral Dosage Forms Life Cycle Management
Life Cycle Extension Strategies
Growth Drivers
Oral Dose Technologies Increasing in Demand
CMO Capabilities Increasing in Demand

Geographic Preferences

Primary Section Takeaways
Use of Emerging Market Suppliers
Oral Dose Manufacturing by Region
Motivations behind Use or Avoidance of Emerging Market Providers

Study Data

Oral Dosage Forms Market Dynamics

Oral Dosage Forms Current Project Volume and Percentage Outsourced
Oral Dosage Forms Project Volume and Percentage Outsourced in Five Years
Characterization of Oral Dosage Form Manufacturing Projects
Number of Oral Dosage Form Contract Manufacturers Currently Used
Number of Oral Dosage Form Contract Manufacturers Used 5 Years from Now
Manufacturing Services Outsourced
Technologies Utilized for Oral Dosage Drug Products
Required Capabilities for Outsourced Oral Dose Manufacturing Projects
Oral Dosage Forms Utilized
Marketed Products Utilizing Each Oral Dosage Form
Outsourced Manufacturing for Each Oral Dosage Form
Outsourced Expenditure by Oral Dosage Form
Annual Spend on Outsourced Oral Dose Manufacturing
Contract Manufacturing Satisfaction Drivers for Oral Dosage Forms
Contract Manufacturing Satisfaction Drivers for Oral Dosage Forms
Use of Emerging Market Suppliers
Regional Perceptions and Preferences for Oral Dosage Drug Product Manufacturing
Oral Dosage Drug Product Manufacturing by Region
Reasons for Not Offshoring Manufacturing to Emerging Markets
Oral Dosage Forms Growth Drivers
Oral Dosage Forms Life Cycle Management
Reasons Service Providers Lose Bids
Use of a Preferred Provider List for Oral Dosage Forms
Number of Preferred Providers
Difficulty Using a Non-Preferred Provider
Frequency of Adding New Preferred Providers
Frequency of Reevaluating Preferred Providers
Service Provider Familiarity
Service Provider Use
Service Provider Preference
Reasons for Service Provider Preference
Verbatim Responses for Service Provider Preference

Service Provider Perceptions and Selection

Most Important Service Provider Attributes for Complex Projects
Service Providers Considered for Complex Projects
Service Provider Preference—Complex Projects
Most Important Service Provider Attributes for Simple Projects
Service Providers Considered for Simple Projects
Service Provider Preference—Simple Projects
Department Influence on CMO Selection

Respondent Demographics

Company Type
Decision-making Responsibility
Job Title
Outsourced Activities
Outsourced Activities
Involvement in Outsourced Activities
Involvement in Drug Development Process
Respondent Location

Additional information

License

, ,